Navigation Links
Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
Date:5/6/2008

31,

2008 2007

Operating expenses:

Research and development $10,478,047 $8,241,804

Marketing 583,702 302,183

General and administrative 2,667,038 1,827,592

Other 28,257 -

Total operating expenses 13,757,044 10,371,579

Loss from operations (13,757,044) (10,371,579)

Other income (expense):

Interest income 550,380 1,031,890

Interest expense (506,856) (220,009)

Other expense (3,395) -

Total other income, net 40,129 811,881

Net loss $(13,716,915) $(9,559,698)

Basic and diluted net loss

per share(1) $(0.42) $(0.34)

Shares used to compute basic

and diluted net loss per

share(1) 32,921,093 28,402,352

(1) As a result of the issuance of 9,240,307 shares of common stock

pursuant to an effective shelf registration in the first quarter of

2008, there is a lack of comparability in the per share amounts

between the 2008 and 2007 periods presented.

CADENCE PHARMACEUTICALS, INC.

(a development stage company)

CONDENSED BALANCE SHEETS

March 31, December 31,

2008 2007

(unaudited)

Assets

Current assets:

Cash and cash equivalents $91,443,447 $55,392,921

Restricted cash 1,981,848 1,981,848

Prepaid expense
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
3. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
4. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
5. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
6. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
7. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
8. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
9. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
10. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
11. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 24, 2013 3SBio Inc. (NASDAQ: ... a leading China -based biotechnology ... biopharmaceutical products, announced today that, at an extraordinary ... shareholders voted in favor of the proposal to ... plan of merger dated February 8, 2013, among ...
(Date:5/23/2013)... 23, 2013  Haemonetics Corporation (NYSE: HAE ) ... & EVP-Business Development, will present at The Deutsche Bank 38 ... Boston, MA on May 29, 2013 at 1:30pm ... The public may access Mr. Lindop,s presentation live ... Haemonetics Haemonetics (NYSE: HAE ) is ...
(Date:5/23/2013)... Tenn. , May 23, 2013  TeamHealth ... 24-hour nurse triage and nurse advice lines, announces ... committee, comprising physician, nursing and administrative leaders, provides ... safe, quality and cost-effective services for hospital clients, ... our national healthcare system evolves, it,s imperative to ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3TeamHealth Medical Call Center Forms Clinical Advisory Committee 2
... 17, 2011 inVentiv Health, offering best-in-class clinical, ... today announced it has signed a definitive agreement ... of global drug development services to the pharmaceutical, ... terms of the transaction were not disclosed. ...
... Ky. and MOUNT ARLINGTON, N.J., May 17, 2011 ... Egros has been appointed to the position of Chief ... Executive Officer. Fabrice Egros has more than ... prior to Xanodyne served in various senior positions in ...
Cached Medicine Technology:inVentiv Health to Acquire PharmaNet 2inVentiv Health to Acquire PharmaNet 3inVentiv Health to Acquire PharmaNet 4inVentiv Health to Acquire PharmaNet 5Xanodyne Pharmaceuticals Appoints New Chief Operating Officer 2
(Date:5/24/2013)... DePuy ASR lawsuit claims ... move forward in courts throughout the country, Bernstein Liebhard ... San Francisco Superior Court on April 25th, a Plaintiff ... DePuy hip lawsuit is voluntarily seeking dismissal of the ... No. CGC11508806; Calif. Super. Ct., San Francisco). , “This ...
(Date:5/24/2013)... HealthDay Reporter , , FRIDAY, May 24 (HealthDay News) ... remarkable. But it was a physical challenge in her ... her sport. "I was an 11-year-old girl with ... was diagnosed by my orthopedic surgeon," said Lewis, who ... Society and the American Academy of Orthopaedic Surgeons so ...
(Date:5/24/2013)... -- Patients hospitalized for heart failure appear to have ... or in the morning, a new study finds. ... heart failure patients admitted in January, on Fridays and ... present their findings Saturday in Portugal at the annual ... Society of Cardiology. "The fact that patients ...
(Date:5/24/2013)... Western University of Health Sciences’ College ... Accreditation” for the next seven years from the American ... “This is a magnificent achievement, and one we expected ... outcomes,” said College of Veterinary Medicine Dean Phillip Nelson, ... the faculty, staff, preceptors, and students that participated in ...
(Date:5/24/2013)... ResortQuest Real Estate® is proud to announce ... at the firm’s Bethany Beach location. , Originally from ... in 1975. Her real estate career began in 1987 ... the real estate business - receptionist, cleaning coordinator, director ... licensed sales associate. , “I am delighted to ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Top-Ranked Golfer Beats Scoliosis 2Health News:Top-Ranked Golfer Beats Scoliosis 3Health News:Monday Best Time for Hospitalization With Heart Failure, Study Says 2Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2
... to Visit Washington, D.C., and Meet with Elected Officials, ... will travel to Washington, D.C., this April 1 to ... of the,Americans with Disabilities Act, support for epilepsy public ... Serwik, 7, is one of 50 young people ...
... Visit Washington, D.C., and,Meet with Elected Officials, ... Nicklaus Schliesmann of Holmen will travel to Washington,D.C., ... and gain their,support for restoration of the Americans ... and more research toward a cure for,epilepsy., ...
... D.C., and Meet with Elected Officials, WASHINGTON, March ... travel to Washington, D.C., this April 1 to meet ... the,Americans with Disabilities Act, support for epilepsy public health,programs ... Smith, 15, is one of 50 young people with ...
... Corporation,(NYSE: STE ) today announced that its ... to $300 million in shares of STERIS common ... as of,February 29, 2008. This share repurchase authorization ... remaining. Through March,13, 2008, the Company has repurchased ...
... in Handling Credit ... Fraud, ... he has reached a settlement with TransUnion over his,lawsuit against the credit ... is the first of six credit reporting companies and banks,which Drew has ...
... LINTHICUM, Md., March 13 Dialysis Corporation,of America ... that it will begin,hosting conference calls in conjunction ... The conference call will he held,Friday morning, March ... interested may dial in at 800-750-4984 using pass-code ...
Cached Medicine News:Health News:Delaware Youth Named National Epilepsy Spokesperson 2Health News:Wisconsin Youths Named National Epilepsy Spokespersons 2Health News:South Carolina Youth Named National Epilepsy Spokesperson 2Health News:STERIS Corporation Announces New $300 Million Share Repurchase Authorization 2Health News:STERIS Corporation Announces New $300 Million Share Repurchase Authorization 3Health News:Leukemia Survivor Reaches Landmark Settlement With TransUnion in ID Theft Case 2Health News:Dialysis Corporation of America Earnings Call Reminder 2
... dryer is an electrophoresis gel vacuum dryer that ... dries these gels onto cellophane or filter paper ... elements which heat gels from above. The drying ... V unit includes power cord, porous gel support, ...
... constant voltage power supply, the 105 is very ... range switch control the output, which is variable ... One, two-position switch toggles the bright LED display ... 105 is equipped with an over current detector ...
... simple techniques such as submarine electrophoresis and ... IEF, the Series 90 Programmable Power Supplies ... 90 Programmable Power Supplies are available in ... 6000V., All models operate in constant voltage, ...
MP-250N and 300N is a new style power supply. It is a versatile microprocessor power supply for horizontal or vertical gel electrophoresis. The unit is programmable and offers constant voltage and co...
Medicine Products: